Given that systemic inflammation has been associated with the pathophysiology of obesity and T2D [58, 59], the anti-inflammatory actions of OXT/OXTR may also be important in attenuating disease progression. Here, OXTR is linked to obesity due to melanocortin 4 receptor deficiency.